William D. Chey, MD, AGAF, FACG, FACP, RFF, received a medical degree and training in internal medicine at Emory University School of Medicine. He completed a fellowship in gastroenterology and has remained as faculty at the University of Michigan in Ann Arbor where he is the Timothy T. Nostrant Collegiate Professor of Gastroenterology. He holds a joint appointment as a Professor of Nutrition Sciences. He was appointed Chief of the Division of Gastroenterology in 2022.

Dr. Chey’s research interests focus on the diagnosis and treatment of disorders of gut brain interaction and H. pylori infection. He has published more than 400 peer-reviewed manuscripts, reviews, book chapters and books yielding an H-index of over 60. He has mentored more than 70 students, residents, fellows and junior faculty, many of which are leaders in Gastroenterology. He is a medical innovator and holds several patents. Dr. Chey is former co-Editor-in-Chief of the American Journal of Gastroenterology and has authored more than 10 national and international clinical practice guidelines. Dr. Chey is a board member of the American College of Gastroenterology, Rome Foundation, International Foundation of GI Disorders, and GI on Demand. He is the Secretary of the American College of Gastroenterology and Vice President of the IFFGD.

He has been elected to Best Doctors since 2001 and received the Dean’s Outstanding Clinician Award and Dean’s Award for Innovation and Commercialization at the University of Michigan. He has received the Distinguished Clinician Award from the American Gastroenterological Association. In 2020, Dr. Chey was awarded honorary membership in the Academy of Nutrition and Dietetics and received the prestigious Berk-Fise Award from the American College of Gastroenterology.

Kate Scarlata, MPH, RDN, LDN is a Boston-based dietitian with 30 years of experience. Kate’s expertise is in gastrointestinal disorders and food intolerance, with a particular focus on the application of the low FODMAP diet for functional gut disorders. She was awarded the Outstanding Massachusetts Dietitian Award and recognized as Boston’s Best Dietitian by Boston Magazine. Kate is the author of numerous books and articles on digestive health topics including the New York Times Best Seller, “The 21 Day Tummy Diet.” Her latest book is “The Low FODMAP Diet Step by Step.” Kate completed her postgraduate training at Brigham and Women’s Hospital, a Harvard Medical School teaching affiliate.

William D. Chey, MD, AGAF, FACG, FACP, RFF, faculty for this event, has the following relevant financial relationship(s) with ineligible companies: he is a consultant to Abbvie, Alnylam, Bioamerica, Gemelli Biotech, Ironwood, Nestle, QOL Medical, Redhill, Takeda, Urovant Sciences, and Vibrant Gastro. He has received grant support and other research funding from Bioamerica, Commonwealth Diagnostics International, and QOL Medical. All relevant financial relationships listed for this individual have been mitigated.

Kate Scarlata, MPH, RDN, LDN, faculty for this event, has the following relevant financial relationship(s) with ineligible companies: she has stock options in Epicured and FODY Food Company. She has received other financial support from Olipop, Mahana Therapeutics, Pendulum, Nestle Health Science, Dr. Schar, QOL Medical, Commonwealth Diagnostics, and FODY Food Company. All relevant financial relationships listed for this individual have been mitigated.

The planners for this educational activity have no relevant financial relationship(s) with ineligible companies to disclose.

An “ineligible company” includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.